Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Susan O'Brien
Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Phase I/Ii Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Assessment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma by Absolute Lymphocyte Counts in 2,126 Patients: 20 Years of Experience at the University of Texas M.D. Anderson Cancer Center
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Imatinib Mesylate Therapy May Overcome the Poor Prognostic Significance of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
‹
1
2
3
4
5
›